• At A Glance
  • Education & Publications
  • Hospital Affiliations
    Profile Video
    Find Me On
    www.cinj.org
    Bio
    Steven K. Libutti, MD, FACS serves as Senior Vice President of Oncology Services for RWJBarnabas Health and is Director of the Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences. He is also a Professor of Surgery at Rutgers Robert Wood Johnson Medical School and an Affiliated Distinguished Professor in Genetics, Rutgers School of Arts and Sciences. Dr. Libutti is a surgical oncologist and internationally known expert in endocrine surgery and the management of neuroendocrine tumors. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas. Dr. Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment and the function of tumor suppressor genes.
  • Medical School

    Columbia Univ College of Physicians and Surgeons, New York, NY

    Internship

    New York Presbyterian Columbia University Medical Center, New York, NY

    Residency

    New York Presbyterian Columbia University Medical Center, New York, NY

    Fellowship

    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

    Publications
    • Title:Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease
      Authors:Keutgen XM, Hammel P, Choyke PL, Libutti SK, Jonasch E, Kebebew E.
      Publisher:Nat Rev Clin Oncol
      Date:2016
      Issue:
      Description: doi: 10.1038/nrclinonc.2016.37. [Epub ahead ofprint] Review. PubMed PMID: 27030075.
    • Title:The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review
      Authors:Serrano OK, Love C, Goldman I, Huang K, Ng N, Abraham T, Da Silva R, Friedmann P, Libutti SK, Kennedy TJ
      Publisher:J Surg Oncol
      Date:2016
      Issue:113(6):640-6
      Description:doi: 10.1002/jso.24190. PubMed PMID: 27115836
    • Title:Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
      Authors:Kwon M, Kim JH, Rybak Y, Luna A, Hun Choi C, Chung JY, Hewitt SM, Adem A, Tubridy E, Lin J, Libutti SK
      Publisher:Oncotarget
      Date:2016
      Issue:
      Description: doi: 10.18632/oncotarget.12784. [Epub ahead of print] PubMed PMID: 27776341.
    • Title:Editorial: Treatment decision making in the era of genetic testing and molecular diagnostics
      Authors:Libutti SK
      Publisher:Surgery
      Date:2017
      Issue:161(1):228-229
      Description:doi: 10.1016/j.surg.2016. 10.009. PubMed PMID: 27863788
    • Title:Of mice and men(in) and what I have learned from both
      Authors:Libutti SK
      Publisher:Surgery
      Date:2017
      Issue:161(1):1-11
      Description:doi: 10.1016/j.surg.2016.10.004. PubMed PMID: 27865595.
    • Title:32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect
      Authors:Chandra D, Selvanesan BC, Yuan Z, Libutti SK, Koba W, Beck A, Zhu K, Casadevall A, Dadachova E, Gravekamp C
      Publisher:Oncotarget
      Date:2017
      Issue:
      Description: doi: 10.18632/oncotarget.15117. [Epub ahead of print]. PubMed PMID: 28186976.
    • Title:Sensitivity of 3-Dimensional Sonography in Preoperative Evaluation of Parathyroid Glands in Patients With Primary Hyperparathyroidism
      Authors:Frank SJ, Goldman-Yassen AE, Koenigsberg T, Libutti SK, Koenigsberg M
      Publisher:J Ultrasound Med.
      Date:2017
      Issue:
      Description:doi: 10.1002/jum.14245. [Epub ahead of print] PubMed PMID: 28543268
    • Title: Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
      Authors:Singh S, Carnaghi C, Buzzoni R, Pommier RF, Raderer M, Tomasek J, Lahner H, Valle JW, Voi M, Bubuteishvili-Pacaud L, Lincy J, Wolin E, Okita N, Libutti SK, Oh DY, Kulke M, Strosberg J, Yao JC, Pavel ME, Fazio N
      Publisher:Neuroendocrinology, RAD001 in Advanced Neuroendocrine Tumors, Fourth Trial (RADIANT-4) Study Group
      Date:2017
      Issue:
      Description:doi: 10.1159/000477585. [Epub ahead of print.] PubMed PMID: 28554173
    • Title:Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas
      Authors:Wang H, Bender A, Wang P, Karakose E, Inabnet WB, Libutti SK, Arnold A, Lambertini L, Stang M, Chen H, Kasai Y, Mahajan M, Kinoshita Y, Fernandez-Ranvier G, Becker TC, Takane KK, Walker LA, Saul S, Chen R, Scott DK, Ferrer J, Antipin Y, Donovan M, Uzilov A
      Publisher:Nat Commun.
      Date:2017
      Issue:3;8(1): 767
      Description:doi: 10.1038/s41467-017-00992-9. PubMed PMID: 28974674
    • Title:Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors
      Authors:Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC
      Publisher:The Oncologist
      Date:2017
      Issue:
      Description:pii: theoncologist.2017-0144. doi: 10.1634/theoncologist.2017-0144. [Epub ahead of print] PubMed PMID: 29242283
    • Title:Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-LindauDisease
      Authors:Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, Kebebew E
      Publisher:JAMA Oncol.
      Date:2018
      Issue:4(1):124-126
      Description:doi:10.1001/jamaoncol.2017.3428. PubMed PMID: 29075773
    • Title:Injection of bulking agents for laryngoplasty
      Authors:Snyder SK, Angelos P, Carty SE, Doherty GM, Howe JR, Lee JA, Libutti SK, Miller BS, Parangi S, Patel KN, Sippel RC, Sturgeon C, Wang TS, Yip L, Zeiger MA
      Publisher:Surgery
      Date:2018
      Issue:163(1):6-8
      Description:doi: 10.1016/ j.surg.2017.08.019. Epub 2017 Nov 9. PubMed PMID: 29129367
    • Title:Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model
      Authors:Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C
      Publisher:Front Genet.
      Date:2018
      Issue:23;9:6
      Description:doi: 10.3389/fgene.2018.00006. eCollection 2018. PMID: 29410677